146 related articles for article (PubMed ID: 17898865)
1. Osteopontin regulates ubiquitin-dependent degradation of Stat1 in murine mammary epithelial tumor cells.
Gao C; Mi Z; Guo H; Kuo PC
Neoplasia; 2007 Sep; 9(9):699-706. PubMed ID: 17898865
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin induces ubiquitin-dependent degradation of STAT1 in RAW264.7 murine macrophages.
Gao C; Guo H; Mi Z; Grusby MJ; Kuo PC
J Immunol; 2007 Feb; 178(3):1870-81. PubMed ID: 17237438
[TBL] [Abstract][Full Text] [Related]
3. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
Mi Z; Guo H; Wai PY; Gao C; Kuo PC
Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin and protein kinase C regulate PDLIM2 activation and STAT1 ubiquitination in LPS-treated murine macrophages.
Guo H; Mi Z; Bowles DE; Bhattacharya SD; Kuo PC
J Biol Chem; 2010 Nov; 285(48):37787-96. PubMed ID: 20889505
[TBL] [Abstract][Full Text] [Related]
5. Differential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behavior.
Mi Z; Guo H; Wai PY; Gao C; Wei J; Kuo PC
J Biol Chem; 2004 Nov; 279(45):46659-67. PubMed ID: 15347645
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
Desai B; Rogers MJ; Chellaiah MA
Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
[TBL] [Abstract][Full Text] [Related]
7. SLIM trims STATs: ubiquitin E3 ligases provide insights for specificity in the regulation of cytokine signaling.
Ungureanu D; Silvennoinen O
Sci STKE; 2005 Oct; 2005(304):pe49. PubMed ID: 16204702
[TBL] [Abstract][Full Text] [Related]
8. PKR-mediated degradation of STAT1 regulates osteoblast differentiation.
Yoshida K; Okamura H; Amorim BR; Hinode D; Yoshida H; Haneji T
Exp Cell Res; 2009 Jul; 315(12):2105-14. PubMed ID: 19230833
[TBL] [Abstract][Full Text] [Related]
9. The role of Osteopontin in tumor metastasis.
Wai PY; Kuo PC
J Surg Res; 2004 Oct; 121(2):228-41. PubMed ID: 15501463
[TBL] [Abstract][Full Text] [Related]
10. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication.
Shirasaki T; Honda M; Yamashita T; Nio K; Shimakami T; Shimizu R; Nakasyo S; Murai K; Shirasaki N; Okada H; Sakai Y; Sato T; Suzuki T; Yoshioka K; Kaneko S
Sci Rep; 2018 Sep; 8(1):13143. PubMed ID: 30177680
[TBL] [Abstract][Full Text] [Related]
11. A transcriptional repressor of osteopontin expression in the 4T1 murine breast cancer cell line.
Gao C; Mi Z; Guo H; Wei J; Wai PY; Kuo PC
Biochem Biophys Res Commun; 2004 Sep; 321(4):1010-6. PubMed ID: 15358129
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin.
Jessen KA; Liu SY; Tepper CG; Karrim J; McGoldrick ET; Rosner A; Munn RJ; Young LJ; Borowsky AD; Cardiff RD; Gregg JP
Breast Cancer Res; 2004; 6(3):R157-69. PubMed ID: 15084239
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin mediates Stat1 degradation to inhibit iNOS transcription in a cecal ligation and puncture model of sepsis.
Guo H; Wai PY; Mi Z; Gao C; Zhang J; Kuo PC
Surgery; 2008 Aug; 144(2):182-8. PubMed ID: 18656624
[TBL] [Abstract][Full Text] [Related]
14. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
Beausoleil MS; Schulze EB; Goodale D; Postenka CO; Allan AL
BMC Cancer; 2011 Jan; 11():25. PubMed ID: 21247495
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
[TBL] [Abstract][Full Text] [Related]
16. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
Oates AJ; Barraclough R; Rudland PS
Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
[TBL] [Abstract][Full Text] [Related]
17. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.
El-Tanani MK; Jin D; Campbell FC; Johnston PG
Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
19. Role of osteopontin in cellular signaling and metastatic phenotype.
El-Tanani MK
Front Biosci; 2008 May; 13():4276-84. PubMed ID: 18508510
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.
Standal T; Hjorth-Hansen H; Rasmussen T; Dahl IM; Lenhoff S; Brenne AT; Seidel C; Baykov V; Waage A; Børset M; Sundan A; Hjertner O
Haematologica; 2004 Feb; 89(2):174-82. PubMed ID: 15003892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
